Interleukin-6 (IL-6) Test in UAE | 390 AED | DHA Licensed Lab at Dubai Healthcare City

Q: What is the IL-6 test used for in clinical diagnosis?

The IL-6 blood test measures interleukin-6 levels to detect inflammation, infection, autoimmune disorders, and cancer progression. It is frequently ordered by oncologists, general physicians, and primary care doctors to evaluate unexplained fevers, monitor cytokine activity in rheumatologic conditions, assess sepsis risk, and track tumor-related inflammation.

Q: How should I prepare for my IL-6 blood test?

You must avoid biotin-containing supplements for at least eight hours before your IL-6 blood collection. Biotin (Vitamin B7) can interfere with the chemiluminescent immunoassay methodology, potentially producing inaccurate results.

Q: What do elevated IL-6 levels indicate about my health?

Elevated IL-6 levels may signal chronic inflammation, active infection, autoimmune flare-ups, or malignancy requiring further investigation. Mild to moderate elevations are commonly seen in chronic inflammatory conditions, while markedly elevated levels warrant urgent evaluation for sepsis or cytokine release syndrome.

Executive Summary & Core Metrics

Executive Summary

The Interleukin-6 (IL-6) test is a high-sensitivity quantitative blood assay using Chemiluminescent Immunoassay (CLIA) technology, measuring circulating IL-6 cytokine levels — a critical biomarker for systemic inflammation, infection severity, autoimmune disease activity, and oncology surveillance. Performed at DNA Labs UAE (DHA License No. 1143), this test delivers 99.9% diagnostic sensitivity via ISO 9001:2015 accredited processing (Cert: INT/EGQ/2509DA/3139). Premium logistics include VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (daily 8 AM – 11 PM). Post-test telephonic clinical guidance is provided by DHA-licensed physicians.

✓Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).

✓Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AM – 11 PM daily).

✓Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed clinicians.

✓Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

The Interleukin-6 (IL-6) assay employs Chemiluminescent Immunoassay (CLIA) technology, which offers superior sensitivity and a broad dynamic range compared to traditional ELISA methods. The test requires 2 mL of plasma collected in a Lavender Top (EDTA) tube, with plasma separation required within 2 hours of collection. Samples are accepted daily by 4 PM with same-day reporting. This methodology is standardized under DHA and MOHAP guidelines for clinical diagnostics in the UAE.

Feature	Our Test — CLIA Platform	Closest Alternative — ELISA
Precision & Sensitivity	99.9% Diagnostic Sensitivity; broad dynamic range (pg/mL to ng/mL)	~85–95% Sensitivity; narrower detection range
Methodology	CLIA — Chemiluminescent Immunoassay (DHA/MOHAP Standard)	ELISA — Enzyme-Linked Immunosorbent Assay
Turnaround Time	Same Day (Sample by 4 PM)	2–3 Business Days
Price	390 AED	Variable (Often 500+ AED)
Home Collection	VIP Mobile Phlebotomy & Temp-Controlled Cold-Chain \| 8 AM – 11 PM	Limited / Not Guaranteed

Physician Insight & Safety Protocols

"As a general practitioner with extensive experience in managing inflammatory and infectious disorders, I emphasize that an IL-6 result must always be interpreted within the full clinical context — including symptom history, physical examination findings, and complementary biomarkers such as C-reactive protein, procalcitonin, and complete blood count with differential. A single elevated IL-6 value does not confirm a specific diagnosis but may guide the urgency of further investigation and therapeutic decision-making."

"In patients with autoimmune conditions, serial IL-6 measurements may help identify subclinical flares before overt symptoms manifest, enabling proactive management. For oncology patients receiving immunotherapy, IL-6 trends can serve as a valuable adjunct for monitoring cytokine-release syndromes."

"I encourage all patients to discuss their results in detail during a dedicated follow-up consultation so that we can correlate laboratory findings with their unique clinical picture."

— Dr. Ajay Singh, General Practitioner, DHA License No. 36234132

Medication Advisory

Important Medication Advisory

Do not discontinue any prescribed medication, including corticosteroids, immunosuppressants, biologics, or anti-inflammatory drugs, without consulting your treating physician. IL-6 testing should complement — never replace — clinical monitoring and therapeutic management. Certain supplements, particularly biotin (Vitamin B7), may interfere with the CLIA assay and must be avoided for at least 8 hours prior to blood collection.

Exclusion Criteria & ER Red Flags

Exclusion Criteria — Do Not Proceed with Routine Outpatient Collection if:

Patient exhibits signs of acute hemodynamic instability (systolic BP < 90 mmHg, tachycardia > 120 bpm).
Known or suspected cytokine release syndrome (CRS) requiring emergency intervention.
Inability to provide informed consent (minors require guardian consent per Federal Decree-Law No. 4 of 2016 on Medical Liability).
Recent major surgery within 14 days (may confound IL-6 interpretation).
Active seizure or altered mental status at time of collection.

ER Red Flags — Seek Immediate Emergency Care if:

IL-6 result exceeds 1000 pg/mL (potential cytokine storm).
Fever > 39°C with rigors and hypotension.
Severe respiratory distress (SpO₂ < 92% on room air).
Petechial rash, confusion, or meningismus with elevated IL-6.
Oliguria or acute kidney injury with systemic inflammatory markers.

Patient FAQ & Clinical Guidance

1. What is the IL-6 test used for in clinical diagnosis?

The IL-6 blood test measures interleukin-6 levels to detect inflammation, infection, autoimmune disorders, and cancer progression. It is frequently ordered by general physicians, oncologists, and primary care doctors to evaluate unexplained fevers, monitor cytokine activity in rheumatologic conditions, assess sepsis risk, and track tumor-related inflammation. IL-6 is also a key biomarker in cytokine release syndrome (CRS) associated with certain immunotherapies and severe infections including COVID-19.

2. How should I prepare for my IL-6 blood test?

You must avoid biotin-containing supplements for at least eight hours before your IL-6 blood collection. Biotin (Vitamin B7) can interfere with the chemiluminescent immunoassay (CLIA) methodology, potentially producing inaccurate results. No fasting is required unless your physician orders additional tests such as a lipid panel or glucose. Inform the phlebotomist of all medications, including over-the-counter supplements, corticosteroids, and biologic therapies, as these may influence IL-6 levels.

3. What do elevated IL-6 levels indicate about my health?

Elevated IL-6 levels may signal chronic inflammation, active infection, autoimmune flare-ups, or malignancy requiring further investigation. Mild to moderate elevations (10–100 pg/mL) are commonly seen in chronic inflammatory conditions such as rheumatoid arthritis, inflammatory bowel disease, and metabolic syndrome. Markedly elevated levels (>500 pg/mL) warrant urgent evaluation for sepsis, cytokine release syndrome, or advanced malignancy. Your physician will correlate IL-6 with CRP, procalcitonin, and clinical findings to determine the appropriate next steps.

UAE Regulatory & Data Privacy Adherence

Regulatory Compliance & Accreditation

Federal Decree-Law No. 45 of 2021 (PDPL): Patient data privacy is maintained in strict accordance with the UAE Personal Data Protection Law, ensuring secure handling of all clinical information.

Federal Law No. 2 of 2019: All laboratory services comply with UAE healthcare facility licensing and clinical diagnostic standards for health information and communication technology.

Federal Decree-Law No. 4 of 2016: Clinical testing safety and patient consent protocols follow the UAE Medical Liability framework.

ISO 9001:2015 Certification: Cert. No. INT/EGQ/2509DA/3139 — Quality Management Systems for Medical Laboratories.

DHA Facility License: 1143

DHA Licensed Reviewer: Dr. Ajay Singh — DHA License No. 36234132

Support: WhatsApp +971 54 548 8731

Clinical & Logistical Metadata

Test Name	Interleukin-6 (IL-6), Chemiluminescent Immunoassay (CLIA)
Price (AED)	390 AED
Turnaround Time	Same Day (Sample accepted by 4 PM)
Sample Type / Matrix	2 mL plasma (1 Lavender Top EDTA tube). Separate plasma within 2 hours of collection. Ship refrigerated or frozen.
Methodology Used	CLIA — Chemiluminescent Immunoassay (DHA/MOHAP Standardized Nomenclature)
ICD-10-CM Code	R79.89 — Other specified abnormal findings of blood chemistry
LOINC Code	1988-5 — Interleukin 6 [Mass/volume] in Serum or Plasma
DHA Facility License & Laboratory Address	DHA License No. 1143 — DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE